News

Under the terms of the agreement, Lupin Pharmaceuticals, USA, will use its 50 person sales force to promote the product to pediatricians. This agreement with Forest Laboratories is

The law also calls upon the state to develop an industry code of conduct and impose fines of $5,000 for every violation. Also, under the new law, all

According to senators Baucus and Conrad who, respectively, chair the Senate finance and budget committees, the institute created by the bill would be a private-entity, non-profit organization responsible

Under the terms of the collaboration, Bristol-Myers Squibb would pay PDL BioPharma an upfront cash payment of $30 million for the development and marketing rights to elotuzumab and

The dismissal of Mr Martini follows a two-year investigation in which police found evidence for fraudulent transactions in return for the falsification of clinical data required for drug

The draft guidance issued by the National Institute for Health and Clinical Excellence (NICE), contends that Roche’s Avastin (bevacizumab), Bayer’s Nexavar (sorafenib), Pfizer’s Sutent (sunitinib) and Wyeth’s Torisel

The licensing agreement is initially restricted to the areas of head and neck cancer. Teva has the right, subject to certain conditions, to extend the licensing agreement to

Mr Teckman was recently president and CEO of Sutura, a medical device manufacturer in Orange Country, California where he led a successful turnaround effort. Mr Teckman is a

The UK will be the first country to market Xamiol. This will take place in the fourth quarter of 2008. Prior to the approval of Xamiol, Leo Pharma